QA: TENAX THERAPEUTICS INC. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2020_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000034956')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 6,180,829
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,559
3 remainder_Assets 177,883
4 LiabilitiesCurrent 2,532,395
5 LiabilitiesNoncurrent 60,379
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,084,111
9 ResearchAndDevelopmentExpense 3,471,153
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 160,901
13 remainder_ComprehensiveNetIncome 16,788,784
  yvar yval
0 Assets 6,365,271
1 Liabilities 2,592,774
2 Expenses 8,555,264
3 Revenues 0
4 StockholdersEquity 3,772,497
5 NetIncome -8,394,363
6 ComprehensiveNetIncome 29.0
7 BaseVar 17,231,497
8 EconomicCapitalRatio 1.45

Edgar->Model Mapping

Feature Distribution

Change over Time